-
1
-
-
79958043675
-
-
National Cancer Institute, Bethesda (MD)
-
Howlader N., Noone A.M., Krapcho M., et al. SEER cancer statistics review, 1975-2008 2011, National Cancer Institute, Bethesda (MD).
-
(2011)
SEER cancer statistics review, 1975-2008
-
-
Howlader, N.1
Noone, A.M.2
Krapcho, M.3
-
2
-
-
84855792427
-
Cancer statistics, 2012
-
Siegel R., Naishadham D., Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012, 62(1):10-29.
-
(2012)
CA Cancer J Clin
, vol.62
, Issue.1
, pp. 10-29
-
-
Siegel, R.1
Naishadham, D.2
Jemal, A.3
-
3
-
-
84872967522
-
Cancer statistics, 2013
-
Siegel R., Naishadham D., Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013, 63(1):11-30.
-
(2013)
CA Cancer J Clin
, vol.63
, Issue.1
, pp. 11-30
-
-
Siegel, R.1
Naishadham, D.2
Jemal, A.3
-
4
-
-
0142008446
-
Undertreatment strongly decreases prognosis of breast cancer in elderly women
-
Bouchardy C., Rapiti E., Fioretta G., et al. Undertreatment strongly decreases prognosis of breast cancer in elderly women. JClin Oncol 2003, 21(19):3580-3587.
-
(2003)
JClin Oncol
, vol.21
, Issue.19
, pp. 3580-3587
-
-
Bouchardy, C.1
Rapiti, E.2
Fioretta, G.3
-
5
-
-
83355174078
-
Improvement in breast cancer outcomes over time: are older women missing out?
-
Eng
-
Smith B.D., Jiang J., McLaughlin S.S., et al. Improvement in breast cancer outcomes over time: are older women missing out?. JClin Oncol 2011, 29:4647-4653. Eng.
-
(2011)
JClin Oncol
, vol.29
, pp. 4647-4653
-
-
Smith, B.D.1
Jiang, J.2
McLaughlin, S.S.3
-
6
-
-
33947425240
-
Effect of undertreatment on the disparity in age-related breast cancer-specific survival among older women
-
Owusu C., Lash T.L., Silliman R.A. Effect of undertreatment on the disparity in age-related breast cancer-specific survival among older women. Breast Cancer Res Treat 2007, 102(2):227-236.
-
(2007)
Breast Cancer Res Treat
, vol.102
, Issue.2
, pp. 227-236
-
-
Owusu, C.1
Lash, T.L.2
Silliman, R.A.3
-
7
-
-
84859140429
-
Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA)
-
Biganzoli L., Wildiers H., Oakman C., et al. Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA). Lancet Oncol 2012, 13(4):e148-e160.
-
(2012)
Lancet Oncol
, vol.13
, Issue.4
-
-
Biganzoli, L.1
Wildiers, H.2
Oakman, C.3
-
8
-
-
84874586547
-
Adjuvant therapy of breast cancer in women 70years of age and older: tough decisions, high stakes
-
Jones E.L., Leak A., Muss H.B. Adjuvant therapy of breast cancer in women 70years of age and older: tough decisions, high stakes. Oncology (Williston Park) 2012, 26(9):793-801.
-
(2012)
Oncology (Williston Park)
, vol.26
, Issue.9
, pp. 793-801
-
-
Jones, E.L.1
Leak, A.2
Muss, H.B.3
-
9
-
-
0037018496
-
Understanding the treatment preferences of seriously ill patients
-
Fried T.R., Bradley E.H., Towle V.R., et al. Understanding the treatment preferences of seriously ill patients. NEngl J Med 2002, 346(14):1061-1066.
-
(2002)
NEngl J Med
, vol.346
, Issue.14
, pp. 1061-1066
-
-
Fried, T.R.1
Bradley, E.H.2
Towle, V.R.3
-
10
-
-
84881318431
-
-
ePrognosis. 2012. Available at: Accessed February 12
-
Lee S, Smith AK, Widera EW, etal. ePrognosis. 2012. Available at: Accessed February 12, 2013. http://www.eprognosis.org.
-
(2013)
-
-
Lee, S.1
Smith, A.K.2
Widera, E.W.3
-
11
-
-
84862909269
-
Prognostic indices for older adults: a systematic review
-
Yourman L.C., Lee S.J., Schonberg M.A., et al. Prognostic indices for older adults: a systematic review. JAMA 2012, 307(2):182-192.
-
(2012)
JAMA
, vol.307
, Issue.2
, pp. 182-192
-
-
Yourman, L.C.1
Lee, S.J.2
Schonberg, M.A.3
-
12
-
-
0035865149
-
Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer
-
Ravdin P.M., Siminoff L.A., Davis G.J., et al. Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer. JClin Oncol 2001, 19(4):980-991.
-
(2001)
JClin Oncol
, vol.19
, Issue.4
, pp. 980-991
-
-
Ravdin, P.M.1
Siminoff, L.A.2
Davis, G.J.3
-
13
-
-
4444315066
-
Probabilities of death from breast cancer and other causes among female breast cancer patients
-
Schairer C., Mink P.J., Carroll L., et al. Probabilities of death from breast cancer and other causes among female breast cancer patients. JNatl Cancer Inst 2004, 96(17):1311-1321.
-
(2004)
JNatl Cancer Inst
, vol.96
, Issue.17
, pp. 1311-1321
-
-
Schairer, C.1
Mink, P.J.2
Carroll, L.3
-
14
-
-
0037080281
-
Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study
-
Repetto L., Fratino L., Audisio R.A., et al. Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study. JClin Oncol 2002, 20(2):494-502.
-
(2002)
JClin Oncol
, vol.20
, Issue.2
, pp. 494-502
-
-
Repetto, L.1
Fratino, L.2
Audisio, R.A.3
-
15
-
-
79952628117
-
Screening older cancer patients for a Comprehensive Geriatric Assessment: a comparison of three instruments
-
Owusu C., Koroukian S.M., Schluchter M., et al. Screening older cancer patients for a Comprehensive Geriatric Assessment: a comparison of three instruments. JGeriatr Oncol 2011, 2:121-129.
-
(2011)
JGeriatr Oncol
, vol.2
, pp. 121-129
-
-
Owusu, C.1
Koroukian, S.M.2
Schluchter, M.3
-
16
-
-
34249774066
-
Comprehensive geriatric assessment for older patients with cancer
-
Extermann M., Hurria A. Comprehensive geriatric assessment for older patients with cancer. JClin Oncol 2007, 25(14):1824-1831.
-
(2007)
JClin Oncol
, vol.25
, Issue.14
, pp. 1824-1831
-
-
Extermann, M.1
Hurria, A.2
-
17
-
-
24044454968
-
Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG)
-
Extermann M., Aapro M., Bernabei R., et al. Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). Crit Rev Oncol Hematol 2005, 55(3):241-252.
-
(2005)
Crit Rev Oncol Hematol
, vol.55
, Issue.3
, pp. 241-252
-
-
Extermann, M.1
Aapro, M.2
Bernabei, R.3
-
18
-
-
84855701468
-
Validation of the G8 screening tool in geriatric oncology: the ONCODAGE project
-
Soubeyran P., Bellera C., Goyard J., et al. Validation of the G8 screening tool in geriatric oncology: the ONCODAGE project. JClin Oncol 2011, 29(15S):550S.
-
(2011)
JClin Oncol
, vol.29
, Issue.15 S
-
-
Soubeyran, P.1
Bellera, C.2
Goyard, J.3
-
19
-
-
33846905273
-
Apilot study of the vulnerable elders survey-13 compared with the comprehensive geriatric assessment for identifying disability in older patients with prostate cancer who receive androgen ablation
-
Mohile S.G., Bylow K., Dale W., et al. Apilot study of the vulnerable elders survey-13 compared with the comprehensive geriatric assessment for identifying disability in older patients with prostate cancer who receive androgen ablation. Cancer 2007, 109(4):802-810.
-
(2007)
Cancer
, vol.109
, Issue.4
, pp. 802-810
-
-
Mohile, S.G.1
Bylow, K.2
Dale, W.3
-
20
-
-
77951624378
-
Detecting disabilities in older patients with cancer: comparison between comprehensive geriatric assessment and vulnerable elders survey-13
-
Luciani A., Ascione G., Bertuzzi C., et al. Detecting disabilities in older patients with cancer: comparison between comprehensive geriatric assessment and vulnerable elders survey-13. JClin Oncol 2010, 28(12):2046-2050.
-
(2010)
JClin Oncol
, vol.28
, Issue.12
, pp. 2046-2050
-
-
Luciani, A.1
Ascione, G.2
Bertuzzi, C.3
-
21
-
-
79952912927
-
Screening for a geriatric risk profile in older cancer patients: a comparative study of the predictive validity of three screening tools
-
Kenis C., Schuermans H., Van Custem E., et al. Screening for a geriatric risk profile in older cancer patients: a comparative study of the predictive validity of three screening tools. Crit Rev Oncol Hematol 2009, 72(Suppl):22.
-
(2009)
Crit Rev Oncol Hematol
, vol.72
, Issue.SUPPL
, pp. 22
-
-
Kenis, C.1
Schuermans, H.2
Van Custem, E.3
-
22
-
-
79953836199
-
Implementing a geriatric assessment in cooperative group clinical cancer trials: CALGB 360401
-
Hurria A., Cirrincione C.T., Muss H.B., et al. Implementing a geriatric assessment in cooperative group clinical cancer trials: CALGB 360401. JClin Oncol 2011, 29(10):1290-1296.
-
(2011)
JClin Oncol
, vol.29
, Issue.10
, pp. 1290-1296
-
-
Hurria, A.1
Cirrincione, C.T.2
Muss, H.B.3
-
23
-
-
79955043830
-
Association of cancer with geriatric syndromes in older Medicare beneficiaries
-
Mohile S.G., Fan L., Reeve E., et al. Association of cancer with geriatric syndromes in older Medicare beneficiaries. JClin Oncol 2011, 29(11):1458-1464.
-
(2011)
JClin Oncol
, vol.29
, Issue.11
, pp. 1458-1464
-
-
Mohile, S.G.1
Fan, L.2
Reeve, E.3
-
24
-
-
84862575323
-
Predicting the risk of chemotherapy toxicity in older patients: the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score
-
Extermann M., Boler I., Reich R.R., et al. Predicting the risk of chemotherapy toxicity in older patients: the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score. Cancer 2012, 118(13):3377-3386.
-
(2012)
Cancer
, vol.118
, Issue.13
, pp. 3377-3386
-
-
Extermann, M.1
Boler, I.2
Reich, R.R.3
-
25
-
-
80052704591
-
Predicting chemotherapy toxicity in older adults with cancer: a Prospective Multicenter Study
-
Hurria A., Togawa K., Mohile S.G., et al. Predicting chemotherapy toxicity in older adults with cancer: a Prospective Multicenter Study. JClin Oncol 2011, 29(25):3457-3465.
-
(2011)
JClin Oncol
, vol.29
, Issue.25
, pp. 3457-3465
-
-
Hurria, A.1
Togawa, K.2
Mohile, S.G.3
-
26
-
-
78650717087
-
Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast
-
Correa C., McGale P., Taylor C., et al. Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. JNatl Cancer Inst Monographs 2010, 2010(41):162-177.
-
(2010)
JNatl Cancer Inst Monographs
, vol.2010
, Issue.41
, pp. 162-177
-
-
Correa, C.1
McGale, P.2
Taylor, C.3
-
27
-
-
33644972703
-
Prospective study of wide excision alone for ductal carcinoma in situ of the breast
-
Wong J.S., Kaelin C.M., Troyan S.L., et al. Prospective study of wide excision alone for ductal carcinoma in situ of the breast. JClin Oncol 2006, 24(7):1031-1036.
-
(2006)
JClin Oncol
, vol.24
, Issue.7
, pp. 1031-1036
-
-
Wong, J.S.1
Kaelin, C.M.2
Troyan, S.L.3
-
28
-
-
73949085809
-
Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group
-
Hughes L.L., Wang M., Page D.L., et al. Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group. JClin Oncol 2009, 27(32):5319-5324.
-
(2009)
JClin Oncol
, vol.27
, Issue.32
, pp. 5319-5324
-
-
Hughes, L.L.1
Wang, M.2
Page, D.L.3
-
29
-
-
84881312594
-
RTOG 9804: a prospective randomized trial for "good risk" ductal carcinoma in situ (DCIS), comparing radiation (RT) to observation (OBS).
-
JClin Oncol 2012;30(suppl):p. abstract
-
McCormick B. RTOG 9804: a prospective randomized trial for "good risk" ductal carcinoma in situ (DCIS), comparing radiation (RT) to observation (OBS). Chicago (IL): 2012 ASCO Annual Meeting. JClin Oncol 2012;30(suppl):p. abstract 1004.
-
Chicago (IL): 2012 ASCO Annual Meeting.
, pp. 1004
-
-
McCormick, B.1
-
30
-
-
77953248475
-
Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies
-
Blows F.M., Driver K.E., Schmidt M.K., et al. Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies. PLoS Med 2010, 7(5):e1000279.
-
(2010)
PLoS Med
, vol.7
, Issue.5
-
-
Blows, F.M.1
Driver, K.E.2
Schmidt, M.K.3
-
31
-
-
0029759541
-
Annual hazard rates of recurrence for breast cancer after primary therapy
-
Saphner T., Tormey D.C., Gray R. Annual hazard rates of recurrence for breast cancer after primary therapy. JClin Oncol 1996, 14(10):2738-2746.
-
(1996)
JClin Oncol
, vol.14
, Issue.10
, pp. 2738-2746
-
-
Saphner, T.1
Tormey, D.C.2
Gray, R.3
-
32
-
-
19344364880
-
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials
-
Abe O., Abe R., Enomoto K., et al. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005, 365(9472):1687-1717.
-
(2005)
Lancet
, vol.365
, Issue.9472
, pp. 1687-1717
-
-
Abe, O.1
Abe, R.2
Enomoto, K.3
-
33
-
-
84862242969
-
Is adjuvant chemotherapy useful for women with luminal a breast cancer?
-
Coates A.S., Colleoni M., Goldhirsch A. Is adjuvant chemotherapy useful for women with luminal a breast cancer?. JClin Oncol 2012, 30(12):1260-1263.
-
(2012)
JClin Oncol
, vol.30
, Issue.12
, pp. 1260-1263
-
-
Coates, A.S.1
Colleoni, M.2
Goldhirsch, A.3
-
34
-
-
33744814477
-
Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer
-
Paik S., Tang G., Shak S., et al. Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. JClin Oncol 2006, 24(23):3726-3734.
-
(2006)
JClin Oncol
, vol.24
, Issue.23
, pp. 3726-3734
-
-
Paik, S.1
Tang, G.2
Shak, S.3
-
35
-
-
77951637777
-
Prediction of risk of distant recurrence using the 21-gene recurrence score in node-negative and node-positive postmenopausal patients with breast cancer treated with anastrozole or tamoxifen: a TransATAC study
-
Dowsett M., Cuzick J., Wale C., et al. Prediction of risk of distant recurrence using the 21-gene recurrence score in node-negative and node-positive postmenopausal patients with breast cancer treated with anastrozole or tamoxifen: a TransATAC study. JClin Oncol 2010, 28(11):1829-1834.
-
(2010)
JClin Oncol
, vol.28
, Issue.11
, pp. 1829-1834
-
-
Dowsett, M.1
Cuzick, J.2
Wale, C.3
-
36
-
-
57449098840
-
Human epidermal growth factor receptor 2 overexpression as a prognostic factor in a large tissue microarray series of node-negative breast cancers
-
Chia S., Norris B., Speers C., et al. Human epidermal growth factor receptor 2 overexpression as a prognostic factor in a large tissue microarray series of node-negative breast cancers. JClin Oncol 2008, 26(35):5697-5704.
-
(2008)
JClin Oncol
, vol.26
, Issue.35
, pp. 5697-5704
-
-
Chia, S.1
Norris, B.2
Speers, C.3
-
37
-
-
77955551055
-
American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer
-
Burstein H.J., Prestrud A.A., Seidenfeld J., et al. American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer. JClin Oncol 2010, 28(23):3784-3796.
-
(2010)
JClin Oncol
, vol.28
, Issue.23
, pp. 3784-3796
-
-
Burstein, H.J.1
Prestrud, A.A.2
Seidenfeld, J.3
-
38
-
-
42949108170
-
Efficacy, toxicity, and quality of life in older women with early-stage breast cancer treated with letrozole or placebo after 5years of tamoxifen: NCIC CTG intergroup trial MA.17
-
Muss H.B., Tu D., Ingle J.N., et al. Efficacy, toxicity, and quality of life in older women with early-stage breast cancer treated with letrozole or placebo after 5years of tamoxifen: NCIC CTG intergroup trial MA.17. JClin Oncol 2008, 26(12):1956-1964.
-
(2008)
JClin Oncol
, vol.26
, Issue.12
, pp. 1956-1964
-
-
Muss, H.B.1
Tu, D.2
Ingle, J.N.3
-
39
-
-
77952590456
-
Polypharmacy in older adults with cancer
-
Maggiore R.J., Gross C.P., Hurria A. Polypharmacy in older adults with cancer. Oncologist 2010, 15(5):507-522.
-
(2010)
Oncologist
, vol.15
, Issue.5
, pp. 507-522
-
-
Maggiore, R.J.1
Gross, C.P.2
Hurria, A.3
-
40
-
-
84868204335
-
Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review
-
Murphy C.C., Bartholomew L.K., Carpentier M.Y., et al. Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review. Breast Cancer Res Treat 2012, 134(2):459-478.
-
(2012)
Breast Cancer Res Treat
, vol.134
, Issue.2
, pp. 459-478
-
-
Murphy, C.C.1
Bartholomew, L.K.2
Carpentier, M.Y.3
-
41
-
-
45549095232
-
Adherence to oral endocrine therapy for breast cancer: a nursing perspective
-
Miaskowski C., Shockney L., Chelbowski R.T. Adherence to oral endocrine therapy for breast cancer: a nursing perspective. Clin J Oncol Nurs 2008, 12(2):213-221.
-
(2008)
Clin J Oncol Nurs
, vol.12
, Issue.2
, pp. 213-221
-
-
Miaskowski, C.1
Shockney, L.2
Chelbowski, R.T.3
-
42
-
-
84856636292
-
Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials
-
Albain K., Anderson S., Arriagada R., et al. Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials. Lancet 2012, 379(9814):432-444.
-
(2012)
Lancet
, vol.379
, Issue.9814
, pp. 432-444
-
-
Albain, K.1
Anderson, S.2
Arriagada, R.3
-
43
-
-
62449193617
-
Docetaxel with cyclophosphamide is associated with an overall survival benefit compared with doxorubicin and cyclophosphamide: 7-year follow-up of US oncology research trial 9735
-
Jones S., Holmes F.A., O'Shaughnessy J., et al. Docetaxel with cyclophosphamide is associated with an overall survival benefit compared with doxorubicin and cyclophosphamide: 7-year follow-up of US oncology research trial 9735. JClin Oncol 2009, 27(8):1177-1183.
-
(2009)
JClin Oncol
, vol.27
, Issue.8
, pp. 1177-1183
-
-
Jones, S.1
Holmes, F.A.2
O'Shaughnessy, J.3
-
44
-
-
80053253110
-
Adjuvant docetaxel/cyclophosphamide in breast cancer patients over the age of 70: results of an observational study
-
Freyer G., Campone M., Peron J., et al. Adjuvant docetaxel/cyclophosphamide in breast cancer patients over the age of 70: results of an observational study. Crit Rev Oncol Hematol 2011, 80(3):466-473.
-
(2011)
Crit Rev Oncol Hematol
, vol.80
, Issue.3
, pp. 466-473
-
-
Freyer, G.1
Campone, M.2
Peron, J.3
-
45
-
-
20044388527
-
Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer
-
Muss H.B., Woolf S., Berry D., et al. Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer. JAMA 2005, 293(9):1073-1081.
-
(2005)
JAMA
, vol.293
, Issue.9
, pp. 1073-1081
-
-
Muss, H.B.1
Woolf, S.2
Berry, D.3
-
46
-
-
58149339881
-
Impact of chemotherapy dose intensity on cancer patient outcomes
-
Lyman G.H. Impact of chemotherapy dose intensity on cancer patient outcomes. JNatl Compr Canc Netw 2009, 7(1):99-108.
-
(2009)
JNatl Compr Canc Netw
, vol.7
, Issue.1
, pp. 99-108
-
-
Lyman, G.H.1
-
47
-
-
37049183697
-
Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene
-
Slamon D.J., Clark G.M., Wong S.G., et al. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987, 235(4785):177-182.
-
(1987)
Science
, vol.235
, Issue.4785
, pp. 177-182
-
-
Slamon, D.J.1
Clark, G.M.2
Wong, S.G.3
-
48
-
-
0034607235
-
Tumor characteristics and clinical outcome of elderly women with breast cancer
-
Diab S.G., Elledge R.M., Clark G.M. Tumor characteristics and clinical outcome of elderly women with breast cancer. JNatl Cancer Inst 2000, 92(7):550-556.
-
(2000)
JNatl Cancer Inst
, vol.92
, Issue.7
, pp. 550-556
-
-
Diab, S.G.1
Elledge, R.M.2
Clark, G.M.3
-
49
-
-
84866407689
-
Safety of adjuvant trastuzumab for HER-2-overexpressing elderly breast cancer patients: a multicenter cohort study
-
Sawaki M., Mukai H., Tokudome N., et al. Safety of adjuvant trastuzumab for HER-2-overexpressing elderly breast cancer patients: a multicenter cohort study. Breast Cancer 2012, 19(3):253-258.
-
(2012)
Breast Cancer
, vol.19
, Issue.3
, pp. 253-258
-
-
Sawaki, M.1
Mukai, H.2
Tokudome, N.3
-
50
-
-
80053539103
-
Adjuvant Trastuzumab in HER2-Positive Breast Cancer
-
Slamon D., Eiermann W., Robert N., et al. Adjuvant Trastuzumab in HER2-Positive Breast Cancer. NEngl J Med 2011, 365(14):1273-1283.
-
(2011)
NEngl J Med
, vol.365
, Issue.14
, pp. 1273-1283
-
-
Slamon, D.1
Eiermann, W.2
Robert, N.3
-
51
-
-
84865432875
-
PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2
-
Wishart G.C., Bajdik C.D., Dicks E., et al. PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2. Br J Cancer 2012, 107(5):800-807.
-
(2012)
Br J Cancer
, vol.107
, Issue.5
, pp. 800-807
-
-
Wishart, G.C.1
Bajdik, C.D.2
Dicks, E.3
-
52
-
-
4344707888
-
Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer
-
Fyles A.W., McCready D.R., Manchul L.A., et al. Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. NEngl J Med 2004, 351(10):963-970.
-
(2004)
NEngl J Med
, vol.351
, Issue.10
, pp. 963-970
-
-
Fyles, A.W.1
McCready, D.R.2
Manchul, L.A.3
-
53
-
-
4344628403
-
Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer
-
Hughes K.S., Schnaper L.A., Berry D., et al. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. NEngl J Med 2004, 351(10):971-977.
-
(2004)
NEngl J Med
, vol.351
, Issue.10
, pp. 971-977
-
-
Hughes, K.S.1
Schnaper, L.A.2
Berry, D.3
-
54
-
-
77955859047
-
Lumpectomy plus tamoxifen with or without irradiation in women age 70 or older with early breast cancer.
-
ASCO Meeting Abstracts. J Clin Oncol 2010;:abstract
-
Hughes KS, Schnaper LA, Cirrincione C, etal. Lumpectomy plus tamoxifen with or without irradiation in women age 70 or older with early breast cancer. ASCO Meeting Abstracts. J Clin Oncol 2010;28(Suppl 15):abstract 507.
-
, Issue.28 SUPPL 15
, pp. 507
-
-
Hughes, K.S.1
Schnaper, L.A.2
Cirrincione, C.3
-
55
-
-
81055155920
-
Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials
-
Darby S., McGale P., Correa C., et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet 2011, 378(9804):1707-1716.
-
(2011)
Lancet
, vol.378
, Issue.9804
, pp. 1707-1716
-
-
Darby, S.1
McGale, P.2
Correa, C.3
-
56
-
-
84860166698
-
Molecular profiling assays in breast cancer: are we ready for prime time?
-
Gokmen-Polar Y., Badve S. Molecular profiling assays in breast cancer: are we ready for prime time?. Oncology 2012, 26(4):350-357.
-
(2012)
Oncology
, vol.26
, Issue.4
, pp. 350-357
-
-
Gokmen-Polar, Y.1
Badve, S.2
-
57
-
-
76649099557
-
Long-term results of hypofractionated radiation therapy for breast cancer
-
Whelan T.J., Pignol J.P., Levine M.N., et al. Long-term results of hypofractionated radiation therapy for breast cancer. NEngl J Med 2010, 362(6):513-520.
-
(2010)
NEngl J Med
, vol.362
, Issue.6
, pp. 513-520
-
-
Whelan, T.J.1
Pignol, J.P.2
Levine, M.N.3
-
58
-
-
79961128669
-
Fractionation for whole breast irradiation: an American Society for Radiation Oncology (ASTRO) evidence-based guideline
-
Smith B.D., Bentzen S.M., Correa C.R., et al. Fractionation for whole breast irradiation: an American Society for Radiation Oncology (ASTRO) evidence-based guideline. Int J Radiat Oncol Biol Phys 2011, 81(1):59-68.
-
(2011)
Int J Radiat Oncol Biol Phys
, vol.81
, Issue.1
, pp. 59-68
-
-
Smith, B.D.1
Bentzen, S.M.2
Correa, C.R.3
-
59
-
-
67649519727
-
Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO)
-
Smith B.D., Arthur D.W., Buchholz T.A., et al. Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). Int J Radiat Oncol Biol Phys 2009, 74(4):987-1001.
-
(2009)
Int J Radiat Oncol Biol Phys
, vol.74
, Issue.4
, pp. 987-1001
-
-
Smith, B.D.1
Arthur, D.W.2
Buchholz, T.A.3
-
60
-
-
0028148836
-
Statement of the American Society of Human Genetics on genetic testing for breast and ovarian cancer predisposition
-
Anonymous
-
Statement of the American Society of Human Genetics on genetic testing for breast and ovarian cancer predisposition. Am J Hum Genet 1994, 55:i-iv. Anonymous.
-
(1994)
Am J Hum Genet
, vol.55
-
-
-
61
-
-
36549075573
-
Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric Oncology
-
Wildiers H., Kunkler I., Biganzoli L., et al. Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric Oncology. Lancet Oncol 2007, 8(12):1101-1115.
-
(2007)
Lancet Oncol
, vol.8
, Issue.12
, pp. 1101-1115
-
-
Wildiers, H.1
Kunkler, I.2
Biganzoli, L.3
-
62
-
-
78149483057
-
Triple-negative breast cancer
-
Foulkes W.D., Smith I.E., Reis J.S. Triple-negative breast cancer. NEngl J Med 2010, 363(20):1938-1948.
-
(2010)
NEngl J Med
, vol.363
, Issue.20
, pp. 1938-1948
-
-
Foulkes, W.D.1
Smith, I.E.2
Reis, J.S.3
-
63
-
-
84857530615
-
Testing for discordance at metastatic relapse: does it matter?
-
Chia S. Testing for discordance at metastatic relapse: does it matter?. JClin Oncol 2012, 30(6):575-576.
-
(2012)
JClin Oncol
, vol.30
, Issue.6
, pp. 575-576
-
-
Chia, S.1
-
64
-
-
4944261201
-
Efficacy of first-line letrozole versus tamoxifen as a function of age in postmenopausal women with advanced breast cancer
-
Mouridsen H., Chaudri-Ross H.A. Efficacy of first-line letrozole versus tamoxifen as a function of age in postmenopausal women with advanced breast cancer. Oncologist 2004, 9(5):497-506.
-
(2004)
Oncologist
, vol.9
, Issue.5
, pp. 497-506
-
-
Mouridsen, H.1
Chaudri-Ross, H.A.2
-
65
-
-
70349335347
-
Management of primary and advanced breast cancer in older unfit patients (medical treatment)
-
Aapro M., Monfardini S., Jirillo A., et al. Management of primary and advanced breast cancer in older unfit patients (medical treatment). Cancer Treat Rev 2009, 35(6):503-508.
-
(2009)
Cancer Treat Rev
, vol.35
, Issue.6
, pp. 503-508
-
-
Aapro, M.1
Monfardini, S.2
Jirillo, A.3
-
66
-
-
0026639451
-
Chemotherapy of metastatic breast cancer in the elderly. The Piedmont Oncology Association experience
-
[see comment]
-
Christman K., Muss H.B., Case L.D., et al. Chemotherapy of metastatic breast cancer in the elderly. The Piedmont Oncology Association experience. JAMA 1992, 268(1):57-62. [see comment].
-
(1992)
JAMA
, vol.268
, Issue.1
, pp. 57-62
-
-
Christman, K.1
Muss, H.B.2
Case, L.D.3
-
67
-
-
0036918281
-
Combination versus sequential single-agent therapy in metastatic breast cancer
-
Miles D., von Minckwitz G., Seidman A.D. Combination versus sequential single-agent therapy in metastatic breast cancer. Oncologist 2002, 7(Suppl 6):13-19.
-
(2002)
Oncologist
, vol.7
, Issue.SUPPL 6
, pp. 13-19
-
-
Miles, D.1
von Minckwitz, G.2
Seidman, A.D.3
-
68
-
-
0035869407
-
Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2
-
Slamon D.J., Leyland-Jones B., Shak S., et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. NEngl J Med 2001, 344(11):783-792.
-
(2001)
NEngl J Med
, vol.344
, Issue.11
, pp. 783-792
-
-
Slamon, D.J.1
Leyland-Jones, B.2
Shak, S.3
-
69
-
-
84881314387
-
Trastuzumab-related cardiotoxicity among older breast cancer patients.
-
ASCO Meeting Abstract. J Clin Oncol
-
Gregor M, Zhang N, Niu J, et al. Trastuzumab-related cardiotoxicity among older breast cancer patients. ASCO Meeting Abstract. J Clin Oncol 2012;30(suppl 27): abstract 135.
-
(2012)
, Issue.30 SUPPL 27
, pp. 135
-
-
Gregor, M.1
Zhang, N.2
Niu, J.3
-
70
-
-
33845886440
-
Lapatinib plus capecitabine for HER2-positive advanced breast cancer
-
Geyer C.E., Forster J., Lindquist D., et al. Lapatinib plus capecitabine for HER2-positive advanced breast cancer. NEngl J Med 2006, 355(26):2733-2743.
-
(2006)
NEngl J Med
, vol.355
, Issue.26
, pp. 2733-2743
-
-
Geyer, C.E.1
Forster, J.2
Lindquist, D.3
-
71
-
-
84868520609
-
Trastuzumab emtansine for HER2-positive advanced breast cancer
-
Verma S., Miles D., Gianni L., et al. Trastuzumab emtansine for HER2-positive advanced breast cancer. NEngl J Med 2012, 367(19):1783-1791.
-
(2012)
NEngl J Med
, vol.367
, Issue.19
, pp. 1783-1791
-
-
Verma, S.1
Miles, D.2
Gianni, L.3
-
72
-
-
84861670957
-
Antiresorptive treatment options and bone health in cancer patients-safety profiles and clinical considerations
-
Hadji P., Aapro M., Costa L., et al. Antiresorptive treatment options and bone health in cancer patients-safety profiles and clinical considerations. Cancer Treat Rev 2012, 38(6):815-824.
-
(2012)
Cancer Treat Rev
, vol.38
, Issue.6
, pp. 815-824
-
-
Hadji, P.1
Aapro, M.2
Costa, L.3
-
73
-
-
79551568488
-
Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study
-
Stopeck A.T., Lipton A., Body J.J., et al. Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study. JClin Oncol 2010, 28(35):5132-5139.
-
(2010)
JClin Oncol
, vol.28
, Issue.35
, pp. 5132-5139
-
-
Stopeck, A.T.1
Lipton, A.2
Body, J.J.3
-
74
-
-
22444444683
-
Radiopharmaceuticals for the palliation of painful bone metastasis-a systemic review
-
Bauman G., Charette M., Reid R., et al. Radiopharmaceuticals for the palliation of painful bone metastasis-a systemic review. Radiother Oncol 2005, 75(3):258-270.
-
(2005)
Radiother Oncol
, vol.75
, Issue.3
, pp. 258-270
-
-
Bauman, G.1
Charette, M.2
Reid, R.3
-
75
-
-
77955877759
-
Early palliative care for patients with metastatic non-small-cell lung cancer
-
Temel J.S., Greer J.A., Muzikansky A., et al. Early palliative care for patients with metastatic non-small-cell lung cancer. NEngl J Med 2010, 363(8):733-742.
-
(2010)
NEngl J Med
, vol.363
, Issue.8
, pp. 733-742
-
-
Temel, J.S.1
Greer, J.A.2
Muzikansky, A.3
-
76
-
-
33847386227
-
Comparing hospice and nonhospice patient survival among patients who die within a three-year window
-
Connor S.R., Pyenson B., Fitch K., et al. Comparing hospice and nonhospice patient survival among patients who die within a three-year window. JPain Symptom Manage 2007, 33(3):238-246.
-
(2007)
JPain Symptom Manage
, vol.33
, Issue.3
, pp. 238-246
-
-
Connor, S.R.1
Pyenson, B.2
Fitch, K.3
-
77
-
-
0037811742
-
Barriers to clinical trial participation by older women with breast cancer
-
Kemeny M.M., Peterson B.L., Kornblith A.B., et al. Barriers to clinical trial participation by older women with breast cancer. JClin Oncol 2003, 21(12):2268-2275.
-
(2003)
JClin Oncol
, vol.21
, Issue.12
, pp. 2268-2275
-
-
Kemeny, M.M.1
Peterson, B.L.2
Kornblith, A.B.3
-
78
-
-
32944479538
-
Central role of the research nurse in improving accrual of older persons to cancer treatment trials
-
Best I. Central role of the research nurse in improving accrual of older persons to cancer treatment trials. JClin Oncol 2005, 23(30):7752-7753.
-
(2005)
JClin Oncol
, vol.23
, Issue.30
, pp. 7752-7753
-
-
Best, I.1
-
79
-
-
0036720874
-
Survey of oncologists' perceptions of barriers to accrual of older patients with breast carcinoma to clinical trials
-
Kornblith A.B., Kemeny M., Peterson B.L., et al. Survey of oncologists' perceptions of barriers to accrual of older patients with breast carcinoma to clinical trials. Cancer 2002, 95(5):989-996.
-
(2002)
Cancer
, vol.95
, Issue.5
, pp. 989-996
-
-
Kornblith, A.B.1
Kemeny, M.2
Peterson, B.L.3
-
80
-
-
1942421681
-
The surgical management of elderly cancer patients; recommendations of the SIOG surgical task force
-
Audisio R.A., Bozzetti F., Gennari R., et al. The surgical management of elderly cancer patients; recommendations of the SIOG surgical task force. Eur J Cancer 2004, 40(7):926-938.
-
(2004)
Eur J Cancer
, vol.40
, Issue.7
, pp. 926-938
-
-
Audisio, R.A.1
Bozzetti, F.2
Gennari, R.3
-
81
-
-
37549012238
-
Shall we operate? Preoperative assessment in elderly cancer patients (PACE) can help. A SIOG surgical task force prospective study
-
Audisio R.A., Pope D., Ramesh H.S., et al. Shall we operate? Preoperative assessment in elderly cancer patients (PACE) can help. A SIOG surgical task force prospective study. Crit Rev Oncol Hematol 2008, 65(2):156-163.
-
(2008)
Crit Rev Oncol Hematol
, vol.65
, Issue.2
, pp. 156-163
-
-
Audisio, R.A.1
Pope, D.2
Ramesh, H.S.3
-
82
-
-
34249794845
-
Radiation therapy and the geriatric oncology patient
-
Horiot J.C. Radiation therapy and the geriatric oncology patient. JClin Oncol 2007, 25(14):1930-1935.
-
(2007)
JClin Oncol
, vol.25
, Issue.14
, pp. 1930-1935
-
-
Horiot, J.C.1
-
83
-
-
34249779624
-
International Society of Geriatric Oncology Chemotherapy Taskforce: evaluation of chemotherapy in older patients-an analysis of the medical literature
-
Lichtman S.M., Wildiers H., Chatelut E., et al. International Society of Geriatric Oncology Chemotherapy Taskforce: evaluation of chemotherapy in older patients-an analysis of the medical literature. JClin Oncol 2007, 25(14):1832-1843.
-
(2007)
JClin Oncol
, vol.25
, Issue.14
, pp. 1832-1843
-
-
Lichtman, S.M.1
Wildiers, H.2
Chatelut, E.3
-
84
-
-
0038662715
-
Participation of patients 65 years of age or older in cancer clinical trials
-
Lewis J.H., Kilgore M.L., Goldman D.P., et al. Participation of patients 65 years of age or older in cancer clinical trials. JClin Oncol 2003, 21(7):1383-1389.
-
(2003)
JClin Oncol
, vol.21
, Issue.7
, pp. 1383-1389
-
-
Lewis, J.H.1
Kilgore, M.L.2
Goldman, D.P.3
|